Grünenthal GmbH is a German pharmaceutical company headquartered in Aachen in Germany. It was founded in 1946 as Chemie Grünenthal and has been continuously family-owned. The company was the first to
Headquarters of Grünenthal
former headquarters in Stolberg
Permission for Grünenthal to produce penicillin, dated 23 February 1948
Cases of severe phocomelia induced by Thalidomide
Tapentadol, sold under the brand names Nucynta and Palexia among others, is a synthetic opioid analgesic with a dual mode of action as a highly selective full agonist of the μ-opioid receptor and as a
Grünenthal
…manufacturing sites) Areas served +100 countries worldwide Key people Gabriel Baertschi (CEO) Fabian Raschke (CFO) Uli Brödl (CSO) Jan Adams (CCO) Products Tapentadol Thalidomide Tramadol etc. Revenue €1.8 billion (2023) Owner Wirtz family Number of employees 4,400 (2023) Website www.grunenthal.com Footnotes…
75 mg Nucynta (tapentadol) tablets
Palexia IR 50mg with Australian "controlled drug" warning